Acknowledgment of Reviewers
In This Issue
Mirror Mirror on the Wall, Who Is the Fairest of Them All
A Nice Problem to Have
An Era of Lung Cancer Iconoclasts
E-Cigarettes and Cancer Patients
Adrenal Metastases in Lung Cancer
Facility Characteristics and Quality of Lung Cancer Care in an Integrated Health Care System
Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations
ALK Status Testing in Non–Small-Cell Lung Carcinoma by FISH on ThinPrep Slides with Cytology Material
Predictive Value of One-Dimensional Mean Computed Tomography Value of Ground-Glass Opacity on High-Resolution Images for the Possibility of Future Change
Epigenetic Regulation of Vitamin D Metabolism in Human Lung Adenocarcinoma
Clinical Significance of BIM Deletion Polymorphism in Non–Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation
Signal Transducer and Activator of Transcription 3 as Molecular Therapy for Non–Small-Cell Lung Cancer
Prognostic Impact of Paraneoplastic Cushing’s Syndrome in Small-Cell Lung Cancer
Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non–Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor Receptor Mutation in Either Exon 19 or 21
Redistribution of Health Care Costs after the Adoption of Positron Emission Tomography among Medicare Beneficiaries with Non–Small-Cell Lung Cancer, 1998–2005
Glucocorticoid Receptor Status Is a Principal Determinant of Variability in the Sensitivity of Non–Small-Cell Lung Cancer Cells to Pemetrexed
The Impact of Peer Review of Volume Delineation in Stereotactic Body Radiation Therapy Planning for Primary Lung Cancer
Influence of Preoperative Radiation Field on Postoperative Leak Rates in Esophageal Cancer Patients after Trimodality Therapy
Thymic Carcinoma
Next-Generation Sequencing Reveals a Novel NSCLC ALK F1174V Mutation and Confirms ALK G1202R Mutation Confers High-Level Resistance to Alectinib (CH5424802/RO5424802) in ALK-Rearranged NSCLC Patients Who Progressed on Crizotinib
Germline EGFR T790M Mutation Found in Multiple Members of a Familial Cohort
Phase II Study of Bendamustine in Relapsed Chemotherapy Sensitive or Resistant Small-Cell Lung Cancer
A Novel Fusion of TPR and ALK in Lung Adenocarcinoma
Characterization of Fibroblast Growth Factor Receptor 1 in Small-Cell Lung Cancer
Management of Mediastinal Relapse after Treatment with Stereotactic Body Radiotherapy or Accelerated Hypofractionated Radiotherapy for Stage I/II Non–Small-Cell Lung Cancer
A Randomized, Placebo-Controlled, Multicenter, Biomarker-Selected, Phase 2 Study of Apricoxib in Combination with Erlotinib in Patients with Advanced Non–Small-Cell Lung Cancer
Pseudoprogression after Stereotactic Body Radiotherapy
Lung Carcinomas with EGFR Exon 19 Insertions Are Sensitive to Gefitinib Treatment